|
HY-B1000A-100mg
|
MedChemexpress LLC
|
L-SelenoMethionine [CAS 3211-76-5]
|
|
Cancer-programmed cell death
|
|
|
HY-B1000A-500mg
|
MedChemexpress LLC
|
L-SelenoMethionine [CAS 3211-76-5]
|
|
Cancer-programmed cell death
|
|
|
HY-B1000A-1mL
|
MedChemexpress LLC
|
L-SelenoMethionine [CAS 3211-76-5] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-B0230-500mg
|
MedChemexpress LLC
|
Phenylbutazone [CAS 50-33-9]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0230-1mL
|
MedChemexpress LLC
|
Phenylbutazone [CAS 50-33-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-B0230S-1mg
|
MedChemexpress LLC
|
Phenylbutazone(diphenyl-d10) [CAS 1219794-69-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0230S-10mg
|
MedChemexpress LLC
|
Phenylbutazone(diphenyl-d10) [CAS 1219794-69-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0230S-5mg
|
MedChemexpress LLC
|
Phenylbutazone(diphenyl-d10) [CAS 1219794-69-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0230S2-1mg
|
MedChemexpress LLC
|
Phenylbutazone-13C12 [CAS 1325559-13-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0230S2-5mg
|
MedChemexpress LLC
|
Phenylbutazone-13C12 [CAS 1325559-13-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-B0230S1-500ug
|
MedChemexpress LLC
|
Phenylbutazone-d9 [CAS 1189479-75-1]
|
|
|
|
|
HY-100218A-10mg
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100218A-100mg
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100218A-2mg
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100218A-25mg
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100218A-5mg
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100218A-50mg
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8]
|
|
Cancer-programmed cell death
|
|
|
HY-100218A-1mL
|
MedChemexpress LLC
|
RSL3 [CAS 1219810-16-8] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
